Foreign-Trade Zone (FTZ) 49-Newark and Elizabeth, New Jersey; Authorization of Production Activity; Catalent Pharma Solutions (Pharmaceutical Products), Somerset, New Jersey, 73674 [2020-25542]
Download as PDF
<![CDATA[
73674
Federal Register / Vol. 85, No. 224 / Thursday, November 19, 2020 / Notices
II. Method of Collection
The MOPS–HP sample will consist of
approximately 3,200 hospital locations
for enterprises classified under General
Medical and Surgical Hospitals (NAICS
6221) and sampled in the Service
Annual Survey (SAS). The survey will
be mailed separately from the 2020 SAS
and collected electronically through the
Census Bureau’s Centurion online
reporting system. Respondents will be
sent an initial letter with instructions
detailing how to log into the instrument
and report their information. These
letters will be addressed to the
location’s CNO. In instances where the
CNO is not identifiable, the letter will
be addressed to the hospital’s
administrative office with attention to
the CNO. Collection is scheduled to
begin in the initial months of 2021.
III. Data
OMB Control Number: 0607–XXXX.
Form Number(s): MP–2000.
Type of Review: Regular submission,
New Information Collection Request.
Affected Public: General medical and
surgical hospitals.
Estimated Number of Respondents:
Approximately 3,200.
Estimated Time per Response: 45
minutes.
Estimated Total Annual Burden
Hours: 2,400.
Estimated Total Annual Cost to
Public: $0. (This is not the cost of
respondents’ time, but the indirect costs
respondents may incur for such things
as purchases of specialized software or
hardware needed to report, or
expenditures for accounting or records
maintenance services required
specifically by the collection.)
Respondent’s Obligation: Mandatory.
Legal Authority: Title 13 U.S.C.,
Sections 131 and 182.
IV. Request for Comments
We are soliciting public comments to
permit the Department/Bureau to: (a)
Evaluate whether the proposed
information collection is necessary for
the proper functions of the Department,
including whether the information will
have practical utility; (b) Evaluate the
accuracy of our estimate of the time and
cost burden for this proposed collection,
including the validity of the
methodology and assumptions used; (c)
Evaluate ways to enhance the quality,
utility, and clarity of the information to
be collected; and (d) Minimize the
reporting burden on those who are to
respond, including the use of automated
collection techniques or other forms of
information technology.
Comments that you submit in
response to this notice are a matter of
VerDate Sep<11>2014
19:40 Nov 18, 2020
Jkt 253001
public record. We will include, or
summarize, each comment in our
request to OMB to approve this ICR.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you may ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2020–25580 Filed 11–18–20; 8:45 am]
BILLING CODE 3510–07–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–47–2020]
Foreign-Trade Zone (FTZ) 49—Newark
and Elizabeth, New Jersey;
Authorization of Production Activity;
Catalent Pharma Solutions
(Pharmaceutical Products), Somerset,
New Jersey
On July 17, 2020, Catalent Pharma
Solutions submitted a notification of
proposed production activity to the FTZ
Board for its facility within Subzone
49T, in Somerset, New Jersey.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (85 FR 47166–47167,
August 4, 2020). On November 16, 2020,
the applicant was notified of the FTZ
Board’s decision that no further review
of the activity is warranted at this time.
The production activity described in the
notification was authorized, subject to
the FTZ Act and the FTZ Board’s
regulations, including Section 400.14.
Dated: November 16, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020–25542 Filed 11–18–20; 8:45 am]
BILLING CODE 3510–DS–P
PO 00000
Frm 00005
Fmt 4703
Sfmt 4703
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[S–163–2020]
Approval of Subzone Status; Sager
Electronics; Carrollton, Texas
On September 17, 2020, the Executive
Secretary of the Foreign-Trade Zones
(FTZ) Board docketed an application
submitted by the Metroplex
International Trade Development
Corporation, grantee of FTZ 168,
requesting subzone status subject to the
existing activation limit of FTZ 168, on
behalf of Sager Electronics, in
Carrollton, Texas.
The application was processed in
accordance with the FTZ Act and
Regulations, including notice in the
Federal Register inviting public
comment (85 FR 60130, September 24,
2020). The FTZ staff examiners
reviewed the application and
determined that it meets the criteria for
approval. Pursuant to the authority
delegated to the FTZ Board Executive
Secretary (15 CFR Sec. 400.36(f)), the
application to establish Subzone 168G
was approved on November 16, 2020,
subject to the FTZ Act and the Board’s
regulations, including Section 400.13,
and further subject to FTZ 168’s
1,955.59-acre activation limit.
Dated: November 16, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020–25579 Filed 11–18–20; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–791–826]
Prestressed Concrete Steel Wire
Strand From South Africa: Preliminary
Affirmative Determination of Sales at
Less Than Fair Value, Postponement
of Final Determination, and Extension
of Provisional Measures
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) preliminarily determines
that prestressed concrete steel wire
strand (PC strand) from South Africa is
being, or is likely to be, sold in the
United States at less than fair value. The
period of investigation is April 1, 2019
through March 31, 2020. Interested
parties are invited to comment on this
preliminary determination.
DATES: Applicable November 19, 2020.
AGENCY:
E:\FR\FM\19NON1.SGM
19NON1
]]>Agencies
[Federal Register Volume 85, Number 224 (Thursday, November 19, 2020)]
[Notices]
[Page 73674]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25542]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-47-2020]
Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey;
Authorization of Production Activity; Catalent Pharma Solutions
(Pharmaceutical Products), Somerset, New Jersey
On July 17, 2020, Catalent Pharma Solutions submitted a
notification of proposed production activity to the FTZ Board for its
facility within Subzone 49T, in Somerset, New Jersey.
The notification was processed in accordance with the regulations
of the FTZ Board (15 CFR part 400), including notice in the Federal
Register inviting public comment (85 FR 47166-47167, August 4, 2020).
On November 16, 2020, the applicant was notified of the FTZ Board's
decision that no further review of the activity is warranted at this
time. The production activity described in the notification was
authorized, subject to the FTZ Act and the FTZ Board's regulations,
including Section 400.14.
Dated: November 16, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-25542 Filed 11-18-20; 8:45 am]
BILLING CODE 3510-DS-P
